Patent · US Active

Aptamers inhibiting the enzymatic activity of tyrosinase

US9732348B2 · kind B2 · utility

6Cited by

0References

14Claims

0Family size

Assignees

L V M H Recherché · FR
Institut National de la Sante et de la Recherche Medicale (INSERM) · FR

Inventors

Jean Hubert Cauchard · Orléans, FR
Robin Kurfurst · Val-de-Reuil, FR
Sylvianne Schnebert · Olivet, FR
Eric Dausse · Bordeaux, FR
Jean-Jacques Toulme · Lormont, FR

Key dates

Filing date	Dec 20, 2013
Grant date	Aug 15, 2017
Priority date	—
Expiry date	Dec 20, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/16
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention relates to a DNA aptamer that can inhibit the enzymatic activity of tyrosinase for the conversion of tyrosine into L-DOPA and dopaquinone, and to the dermatological and cosmetic uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.